Position
Chief Executive Officer
Company
Callio Therapeutics
SeattleBiotechnologyHealth CareTherapeuticsDescription
Callio Therapeutics has appointed Zachary Hornby as Chief Executive Officer, effective immediately. Hornby brings extensive experience in leading biotechnology companies through clinical development and financing.
Quick answer
Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer (September 10, 2026). Callio Therapeutics is based in Seattle, Washington, United States.
- Who is the new Chief Executive Officer at Callio Therapeutics?
- Callio Therapeutics named Zachary Hornby Chief Executive Officer, announced September 10, 2026.
- What did Callio Therapeutics announce on September 10, 2026?
- Callio Therapeutics has appointed Zachary Hornby as Chief Executive Officer, effective immediately. Hornby brings extensive experience in leading biotechnology companies through clinical development and financing.
- What does Callio Therapeutics do?
- Callio Therapeutics is a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADC) to enhance cancer therapy.
- Where is Callio Therapeutics based?
- Callio Therapeutics is based in Seattle, Washington, United States.
- Which similar companies made leadership changes around the same time?
- Retension Pharmaceuticals (September 10, 2026), TransCode Therapeutics (September 10, 2026), Alchemab Therapeutics (September 10, 2026) and Panther Life Sciences (September 11, 2026) also announced leadership changes within 45 days of Callio Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- TransCode Therapeutics Appoints John Tattory as Interim Chief Financial Officer (September 10, 2026)
- Alchemab Therapeutics Appoints Dr Ben Porter-Brown as Chief Medical Officer (September 10, 2026)
- Panther Life Sciences Appoints Marcus 'Mounir' Hanana as Chief Executive Officer (September 11, 2026)
- NovoCure Limited Announces Retirement of Director Timothy Scannell (September 9, 2026)
- insitro Appoints Hideo Makimura as Chief Medical Officer (September 8, 2026)
Who to call at Callio Therapeutics, and when
A new leader at Callio Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Callio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Callio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Callio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Callio Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Callio Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.